Log In
BCIQ
Print this Print this
 

ASN-002, TG1042

Also known as: Ad-IFNg, Adenovirus IFN-gamma

  Manage Alerts
Collapse Summary General Information
Company Transgene S.A.
DescriptionAdenoviral vector carrying the interferon (IFN) gamma gene
Molecular Target Not applicable
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPhase I/II
Standard IndicationBasal cell carcinoma (BCC)
Indication DetailsTreat nodular basal cell carcinoma (BCC)
Regulatory Designation
PartnerAscend Biopharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today